A Study to Evaluate the Effect of Dupilumab on Exercise Capacity in Adult Patients With Asthma

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 16, 2020

Primary Completion Date

July 15, 2023

Study Completion Date

July 15, 2023

Conditions
Asthma
Interventions
DRUG

dupilumab

Pre-filled syringe administered by subcutaneous (SC) injections

DRUG

Matching placebo

Pre-filled syringe administered by subcutaneous (SC)

Trial Locations (30)

12159

Regeneron Study Site, Berlin

19140

Temple University Hospital, Philadelphia

21000

CHU Dijon, Dijon

22977

Regeneron Study Site, Großhansdorf

28007

Hospital General Universitario Gregorio Maranon (HGUGM) - Instituto de Investigacion Sanitaria Gregorio Maranon (IiSGM), Madrid

28277

American Health Research, Charlotte

30625

Regeneron Study Site, Hanover

37075

Regeneron Study Site, Hendersonville

44106

UH Cleveland Medical Center, Cleveland

48109

University of Michigan, Ann Arbor

51092

CHU Reims, Reims

52242

University of Iowa Hospitals & Clinics-Roy J. and Lucille A. Carver College of Medicine, Iowa City

55128

IKF Pneumologie Mainz, Helix Medical Excellence Center Mainz, Mainz

56068

Regeneron Study Site, Koblenz

60389

Regeneron Study Site, Frankfurt am Main

60596

IKF Pneumologie GmbH & Co. KG - Institut fuer klinische Forschung Pneumologie Frankfurt (Clinical Research Centre Respiratory Medicine) to IKF Pneumologie Frankfurt GmbH & Co KG., Frankfurt am Main

63739

Praxis Dr. M. Rolke u. Dr. P. Rueckert, Aschaffenburg

66160

University Of Kansas Medical Center, Kansas City

67091

CHU de Strasbourg - Nouvel Hopital Civil, Strasbourg

77030

The University of Texas Medical School at Houston, Houston

84107

Intermountain Medical Center, Murray

90274

Palos Verdes Medical Group (PVMG); Peninsula Research Associates (PRA), Rolling Hills Estates

90509

UCLA Medical Center - Harbor, Torrance

92683

Allianz Research Institute, Westminster

486344

KLB - Gesundheitsforschung Luebeck GmbH, Lübeck

02747

Infinity Medical Research, North Dartmouth

59-300

Regeneron Study Site, Lubin

15-044

Centrum Medycyny Oddechowej, Mroz Spolka Jawna, Bialystok

54-239

Lekarze Specjalisci - J. Malolepszy i Partnerzy, Wroclaw

08907

Hospital Universitario de Bellvitge, Barcelona

All Listed Sponsors
lead

Regeneron Pharmaceuticals

INDUSTRY

NCT04203797 - A Study to Evaluate the Effect of Dupilumab on Exercise Capacity in Adult Patients With Asthma | Biotech Hunter | Biotech Hunter